menu

Medical Program: New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

close
New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Sponsored by

  • Overview

    There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/14/20